Metronomia today announced the contract signing for two EDC trials in oncology with a leading German biotech company.

After an initial phase II leukemia trial with a clincase eCRF has been completed successfully in early 2010 with excellent feedback from investigators and CRAs, our customer decided to go for clincase eCRFs and Metronomia services with subsequent clinical trials in oncolgy.

One contract is for a multinational pivotal leukemia study, the other contract covers a phase II exploratory study in leukemia.

Services provided by Metronomia include eCRF development, deployment and support, user management, training, data hosting, clinical data management and statistical services.